aet02.md
In chevron: Standard TLGs for Clinical Trials Reporting

aet02 can have different levels of row_split

Code
  cat(export_as_txt(res1, lpp = 100))
Output
                                                               A: Drug X    B: Placebo   C: Combination
    MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)    
    ———————————————————————————————————————————————————————————————————————————————————————————————————
    Total number of patients with at least one adverse event   13 (86.7%)   14 (93.3%)     15 (100%)   
    Overall total number of events                                 58           59             99      
    dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)   
    dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)   
    dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)   
    dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)   
    dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)   
    dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)   
    dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)   
    dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)   
    dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)   
    dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)

Code
  cat(export_as_txt(res2, lpp = 100))
Output
    MedDRA System Organ Class                                                                              
      MedDRA Preferred Term                                        A: Drug X    B: Placebo   C: Combination
        MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)    
    ———————————————————————————————————————————————————————————————————————————————————————————————————————
    Total number of patients with at least one adverse event       13 (86.7%)   14 (93.3%)     15 (100%)   
    Overall total number of events                                     58           59             99      
    cl B.2                                                                                                 
      Total number of patients with at least one adverse event     11 (73.3%)   8 (53.3%)      10 (66.7%)  
      Total number of events                                           18           15             20      
      dcd B.2.2.3.1                                                                                        
        Total number of patients with at least one adverse event   8 (53.3%)    6 (40.0%)      7 (46.7%)   
        Total number of events                                         9            7              13      
        dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)   
      dcd B.2.1.2.1                                                                                        
        Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      5 (33.3%)   
        Total number of events                                         9            8              7       
        dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)   
    cl D.1                                                                                                 
      Total number of patients with at least one adverse event     9 (60.0%)    5 (33.3%)      11 (73.3%)  
      Total number of events                                           13           9              19      
      dcd D.1.1.1.1                                                                                        
        Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      7 (46.7%)   
        Total number of events                                         5            7              11      
        dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)   
      dcd D.1.1.4.2                                                                                        
        Total number of patients with at least one adverse event   6 (40.0%)    2 (13.3%)      7 (46.7%)   
        Total number of events                                         8            2              8       
        dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)   
    cl A.1                                                                                                 
      Total number of patients with at least one adverse event     7 (46.7%)    6 (40.0%)      10 (66.7%)  
      Total number of events                                           8            11             16      
      dcd A.1.1.1.2                                                                                        
        Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      6 (40.0%)   
        Total number of events                                         5            10             9       
        dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)   
      dcd A.1.1.1.1                                                                                        
        Total number of patients with at least one adverse event   3 (20.0%)     1 (6.7%)      6 (40.0%)   
        Total number of events                                         3            1              7       
        dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)   
    cl B.1                                                                                                 
      Total number of patients with at least one adverse event     5 (33.3%)    6 (40.0%)      8 (53.3%)   
      Total number of events                                           6            6              12      
      dcd B.1.1.1.1                                                                                        
        Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)   
        Total number of events                                         6            6              12      
        dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)   
    cl C.2                                                                                                 
      Total number of patients with at least one adverse event     6 (40.0%)    4 (26.7%)      8 (53.3%)   
      Total number of events                                           6            4              12      
      dcd C.2.1.2.1                                                                                        
        Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)   
        Total number of events                                         6            4              12      
        dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)   
    cl D.2                                                                                                 
      Total number of patients with at least one adverse event     2 (13.3%)    5 (33.3%)      7 (46.7%)   
      Total number of events                                           3            5              10      
      dcd D.2.1.5.3                                                                                        
        Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)   
        Total number of events                                         3            5              10      
        dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)   
    cl C.1                                                                                                 
      Total number of patients with at least one adverse event     4 (26.7%)    4 (26.7%)      5 (33.3%)   
      Total number of events                                           4            9              10      
      dcd C.1.1.1.3                                                                                        
        Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)   
        Total number of events                                         4            9              10      
        dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)